These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7704488)

  • 1. Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery.
    Shek PN; Suntres ZE; Brooks JI
    J Drug Target; 1994; 2(5):431-42. PubMed ID: 7704488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary delivery of insulin by liposomal carriers.
    Huang YY; Wang CH
    J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of alpha-tocopherol in liposomes promotes the retention of liposome-encapsulated glutathione in the rat lung.
    Suntres ZE; Shek PN
    J Pharm Pharmacol; 1994 Jan; 46(1):23-8. PubMed ID: 8201524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of LPS-induced tissue injury: role of liposomal antioxidants.
    Suntres ZE; Shek PN
    Shock; 1996; 6 Suppl 1():S57-64. PubMed ID: 8828099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alleviation of paraquat-induced lung injury by pretreatment with bifunctional liposomes containing alpha-tocopherol and glutathione.
    Suntres ZE; Shek PN
    Biochem Pharmacol; 1996 Nov; 52(10):1515-20. PubMed ID: 8937465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of phorbol myristate acetate-induced acute lung injury by alpha-tocopherol liposomes.
    Suntres ZE; Shek PN
    J Drug Target; 1995; 3(3):201-8. PubMed ID: 8705253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
    Allen TM; Mehra T; Hansen C; Chin YC
    Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes for Pulmonary Drug Delivery: The Role of Formulation and Inhalation Device Design.
    Elhissi A
    Curr Pharm Des; 2017; 23(3):362-372. PubMed ID: 27848886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations.
    Beck-Broichsitter M; Rieger M; Reul R; Gessler T; Seeger W; Schmehl T
    Eur J Pharm Biopharm; 2013 May; 84(1):106-14. PubMed ID: 23262166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute toxicity study of liposomal antioxidant formulations containing N-acetylcysteine, α-tocopherol, and γ-tocopherol in rats.
    Alipour M; Smith MG; Pucaj K; Suntres ZE
    J Liposome Res; 2012 Jun; 22(2):158-67. PubMed ID: 22401703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition.
    Beaulac C; Clement-Major S; Hawari J; Lagace J
    J Microencapsul; 1997; 14(3):335-48. PubMed ID: 9147283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of different vitamin E carriers intended for pulmonary drug delivery.
    Laouini A; Andrieu V; Vecellio L; Fessi H; Charcosset C
    Int J Pharm; 2014 Aug; 471(1-2):385-90. PubMed ID: 24939617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion.
    Abu-Dahab R; Schäfer UF; Lehr CM
    Eur J Pharm Sci; 2001 Aug; 14(1):37-46. PubMed ID: 11457648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes promote pulmonary glucocorticoid delivery.
    Suntres ZE; Shek PN
    J Drug Target; 1998; 6(3):175-82. PubMed ID: 9888303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug targeting to inflammation: studies on antioxidant surface loaded diclofenac liposomes.
    Jukanti R; Devaraj G; Devaraj R; Apte S
    Int J Pharm; 2011 Jul; 414(1-2):179-85. PubMed ID: 21605645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic uses of antioxidant liposomes.
    Stone WL; Smith M
    Mol Biotechnol; 2004 Jul; 27(3):217-30. PubMed ID: 15247495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients.
    Elhissi AM; Giebultowicz J; Stec AA; Wroczynski P; Ahmed W; Alhnan MA; Phoenix D; Taylor KM
    Int J Pharm; 2012 Oct; 436(1-2):519-26. PubMed ID: 22796173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan-reduced gold nanoparticles: a novel carrier for the preparation of spray-dried liposomes for topical delivery.
    Padamwar MN; Patole MS; Pokharkar VB
    J Liposome Res; 2011 Dec; 21(4):324-32. PubMed ID: 21623705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
    Kim CK; Han JH
    J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.